1 / 8

Liquid Biopsy Market Report Analysis 2020-2026

Liquid Biopsy is a conventional method used to diagnose onset of cancer. The alternative names for liquid biopsy are fluid biopsy or fluid phase biopsy. This is largely a non-invasive method used to track tumors and mutations over a period of time. Doctors are informed about the disease with the help of these observations of the tumoru2019s future.

priyankauke2013
Download Presentation

Liquid Biopsy Market Report Analysis 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liquid Biopsy Market Market Set to Exceed $3,362.6 Million by 2026 | CAGR 21.9%

  2. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 “Liquid Biopsy Market Share, Size, Trends, & Industry Analysis Report, By Technology (PCR Microarrays, NGS); By Sample Type (Blood, Urine, Saliva, Other Body Fluid); By Biomarker (Exosomes, CTC, ctDNA); By Application; By Region and Segment Forecast, 2019-2026” The global liquid biopsy market size is slated to reach USD 3,362.6 million by 2026 at a CAGR of 21.9% according to a news report published by Polaris Market Research. Liquid Biopsy is a conventional method used to diagnose onset of cancer. The alternative names for liquid biopsy are fluid biopsy or fluid phase biopsy. This is largely a non-invasive method used to track tumors and mutations over a period of time. Doctors are informed about the disease with the help of these observations of the tumor’s future. Though being simple and instrumental in early stage detection of cancer, it voices concerns over its adoption. Liquid Biopsy products market has a shortcoming which is it is largely overshadowed by tissue biopsy with the latter being adopted exceptionally. Drivers to the market potential are the increasing number of patients being diagnosed with various types of cancer. The free trials accompanying surgery motivates growth. Minimal invasive surgery method unique to liquid biopsy market cap, invokes huge demand impacting market growth over forthcoming years. A significant driver to growth of liquid biopsy is the reduced number of surgical invasions. This encouraging sign makes it one of the most adopted substitutes for tissue biopsy. An increasing trend followed by key players to shift focus onto research and development activities aiding strategic M&A improves market strength dramatically. Browse Detailed Research Report On Liquid Biopsys Market: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy-market Considering the basis of technology, single gene analysis and multi-gene-parallel analysis (NGS) dominate the liquid biopsy cancer market size. NGS denotes diagnosis of multiple diseases at one instance. PCR is an approach to analyzing mutation among genes. Yet another class of distinction in liquid biopsy market 2018 is based on sample type. The sample is segmented on basis of blood, saliva, urine and other body fluid. Blood sample is the best sample type for customary analyses as blood contains cell free DNA, circulating cell and exosomes that offer them for easy detection leading to detection of cancerous cells in human body. - 2 -

  3. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 Based on biomarker type, the global market outlook to 2026 is segmented into exosomes, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA). CTC biomarkers govern largest market share owing to high awareness levels and accurate tracking results of cancerous cells in the body. CTC marker makes early forays in the initial stages of detection of cancer itself. North America is holding coveted position as per geography in market cap during forecast period. Increased facilitators for diagnosis of cancer and rising number of patients suffering from cancer are factors promoting growth of market. Asia Pacific is exhibited to grow at a faster rate during forecast period. The major players operating in market include Roche Diagnostics, Illumina Inc., Myriad Genetics, Inc., RainDance Technologies, Inc. among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/liquid-biopsy- market/request-for-sample Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-away 1.5. Stakeholders - 3 -

  4. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 2. Executive Summary 2.1. Market definition 2.2. Market segmentation 3. Liquid Biopsy Market Insights 3.1. Liquid Biopsy– Industry snapshot 3.2. Leading Companies 3.3. Key Companies to Watch 3.4. Liquid Biopsy- Ecosystem analysis 3.5. Disease overview 3.6. Commercial Landscape 3.7. Liquid Biopsy market Dynamics 3.7.1. Liquid Biopsy– Market Forces 3.7.2. Liquid Biopsy Market Driver Analysis 3.7.3. Liquid Biopsy Market Restraint/Challenges analysis 3.7.4. Liquid Biopsy market Opportunity Analysis 3.8. Industry analysis - Porter's five forces 3.8.1. Bargaining power of supplier 3.8.2. Bargaining power of buyer 3.8.3. Threat of substitute 3.8.4. Threat of new entrant 3.9. Degree of competition 3.10. Liquid Biopsy market PEST Analysis, 2017 3.11. Liquid Biopsy Market Value Chain Analysis 3.12. Liquid Biopsy Industry Trends 3.13. Competitive Ranking Analysis 4. Liquid Biopsy Market Size and Forecast, 2017-2025 by Technology Types 4.1. Key Findings 4.2. Single Gene Analysis (PCR Microarrays) 4.2.1. Global market estimates and forecasts, 2017 – 2025 4.3. Multi-gene-parallel analysis (NGS) 4.3.1. Global market estimates and forecasts, 2017 – 2025 5. Liquid Biopsy Market Size and Forecast, 2017-2025 by Sample type 5.1. Key Findings 5.2. Blood 5.2.1. Global market estimates and forecasts, 2017 – 2025 5.3. Urine 5.3.1. Global market estimates and forecasts, 2017 – 2025 5.4. Saliva 5.4.1. Global market estimates and forecasts, 2017 – 2025 5.5. Other Body Fluids 5.5.1. Global market estimates and forecasts, 2017 – 2025 6. Liquid Biopsy Market Size and Forecast, 2017-2025 by Biomarker type 6.1. Key Findings 6.2. Exosomes 6.2.1. Global market estimates and forecasts, 2017 – 2025 6.3. CTC 6.3.1. Global market estimates and forecasts, 2017 – 2025 6.4. CTCDNAs 6.4.1. Global market estimates and forecasts, 2017 – 2025 7. Liquid Biopsy Market Size and Forecast, 2017-2025 by Application type 7.1. Key Findings 7.2. Molecular Health Monitoring - 4 -

  5. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 7.2.1. Global market estimates and forecasts, 2017 – 2025 7.3. Therapy Selection for Other Meta Cancer 7.3.1. Global market estimates and forecasts, 2017 – 2025 7.4. Therapy Selection for MBS 7.4.1. Global market estimates and forecasts, 2017 – 2025 8. Liquid Biopsy Market Size and Forecast, 2017-2025 by Region 8.1. Key Findings 8.2. North America 8.2.1. Liquid Biopsy market by Technology type, 2017-2025 8.2.2. Liquid Biopsy market by Sample, 2017-2025 8.2.3. Liquid Biopsy market by Biomarker, 2017-2025 8.2.4. Liquid Biopsy market by Application, 2017-2025 8.2.5. U.S. 8.2.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.2.5.2. Liquid Biopsy market by Sample, 2017-2025 8.2.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.2.5.4. Liquid Biopsy market by Application, 2017-2025 8.2.6. Canada 8.2.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.2.6.2. Liquid Biopsy market by Sample, 2017-2025 8.2.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.2.6.4. Liquid Biopsy market by Application, 2017-2025 8.3. Europe 8.3.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.2. Liquid Biopsy market by Sample, 2017-2025 8.3.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.4. Liquid Biopsy market by Application, 2017-2025 8.3.5. UK 8.3.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.5.2. Liquid Biopsy market by Sample, 2017-2025 8.3.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.5.4. Liquid Biopsy market by Application, 2017-2025 8.3.6. Germany 8.3.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.6.2. Liquid Biopsy market by Sample, 2017-2025 8.3.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.6.4. Liquid Biopsy market by Application, 2017-2025 8.3.7. France 8.3.7.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.7.2. Liquid Biopsy market by Sample, 2017-2025 8.3.7.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.7.4. Liquid Biopsy market by Application, 2017-2025 8.3.8. Italy 8.3.8.1. Liquid Biopsy market by Technology type, 2017-2025 8.3.8.2. Liquid Biopsy market by Sample, 2017-2025 8.3.8.3. Liquid Biopsy market by Biomarker, 2017-2025 8.3.8.4. Liquid Biopsy market by Application, 2017-2025 8.4. Asia-Pacific 8.4.1. Liquid Biopsy market by Technology type, 2017-2025 8.4.2. Liquid Biopsy market by Sample, 2017-2025 8.4.3. Liquid Biopsy market by Biomarker, 2017-2025 8.4.4. Liquid Biopsy market by Application, 2017-2025 - 5 -

  6. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 8.4.5. China 8.4.5.1. 8.4.5.2. 8.4.5.3. 8.4.5.4. 8.4.6. Japan 8.4.6.1. 8.4.6.2. 8.4.6.3. 8.4.6.4. 8.4.7. India 8.4.7.1. 8.4.7.2. 8.4.7.3. 8.4.7.4. 8.5. Latin America 8.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.2. Liquid Biopsy market by Sample, 2017-2025 8.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.4. Liquid Biopsy market by Application, 2017-2025 8.5.5. Brazil 8.5.5.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.5.2. Liquid Biopsy market by Sample, 2017-2025 8.5.5.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.5.4. Liquid Biopsy market by Application, 2017-2025 8.5.6. Mexico 8.5.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.6.2. Liquid Biopsy market by Sample, 2017-2025 8.5.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.6.4. Liquid Biopsy market by Application, 2017-2025 8.5.7. Rest of Latin America 8.5.7.1. Liquid Biopsy market by Technology type, 2017-2025 8.5.7.2. Liquid Biopsy market by Sample, 2017-2025 8.5.7.3. Liquid Biopsy market by Biomarker, 2017-2025 8.5.7.4. Liquid Biopsy market by Application, 2017-2025 8.6. Middle East & Africa 8.6.1. Liquid Biopsy market by Technology type, 2017-2025 8.6.2. Liquid Biopsy market by Sample, 2017-2025 8.6.3. Liquid Biopsy market by Biomarker, 2017-2025 8.6.4. Liquid Biopsy market by Application, 2017-2025 9. Company Profiles 9.1. Roche Diagnostics 9.1.1. Overview 9.1.2. Financials 9.1.3. Product Benchmarking 9.1.4. Recent Developments 9.2. Illumina, Inc. 9.2.1. Overview 9.2.2. Financials 9.2.3. Product Benchmarking 9.2.4. Recent Developments 9.3. Bio-Rad Laboratories Inc. Liquid Biopsy market by Technology type, 2017-2025 Liquid Biopsy market by Sample, 2017-2025 Liquid Biopsy market by Biomarker, 2017-2025 Liquid Biopsy market by Application, 2017-2025 Liquid Biopsy market by Technology type, 2017-2025 Liquid Biopsy market by Sample, 2017-2025 Liquid Biopsy market by Biomarker, 2017-2025 Liquid Biopsy market by Application, 2017-2025 Liquid Biopsy market by Technology type, 2017-2025 Liquid Biopsy market by Sample, 2017-2025 Liquid Biopsy market by Biomarker, 2017-2025 Liquid Biopsy market by Application, 2017-2025 - 6 -

  7. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 9.3.1. Overview 9.3.2. Financials 9.3.3. Product Benchmarking 9.3.4. Recent Developments 9.4. Myriad Genetics, Inc. 9.4.1. Overview 9.4.2. Financials 9.4.3. Product Benchmarking 9.4.4. Recent Developments 9.5. Menarini Silicon Biosystems, Genomic Health, Inc. 9.5.1. Overview 9.5.2. Financials 9.5.3. Product Benchmarking 9.5.4. Recent Developments 9.6. QIAGEN N.V. 9.6.1. Overview 9.6.2. Financials 9.6.3. Product Benchmarking 9.6.4. Recent Developments 9.7. Thermo Fisher Scientific Inc. 9.7.1. Overview 9.7.2. Financials 9.7.3. Product Benchmarking 9.7.4. Recent Developments 9.8. Biocept, Inc. 9.8.1. Overview 9.8.2. Financials 9.8.3. Product Benchmarking 9.8.4. Recent Developments 9.9. Trovagene, Inc. 9.9.1. Overview 9.9.2. Financials 9.9.3. Product Benchmarking 9.9.4. Recent Developments 9.10. RainDance Technologies, Inc. 9.10.1. Overview 9.10.2. Financials 9.10.3. Product Benchmarking 9.10.4. Recent Developments 9.11. Guardant Health, Inc. 9.11.1. Overview 9.11.2. Financials 9.11.3. Product Benchmarking 9.11.4. Recent Developments 9.12. MDx Health SA. 9.12.1. Overview 9.12.2. Financials 9.12.3. Product Benchmarking 9.12.4. Recent Developments Access Press Release on Liquid Biopsys Market: https://www.polarismarketresearch.com/press-releases/liquid-biopsy-market - 7 -

  8. Liquid Biopsy Market Size to Reach $3,362.6 Million by 2026 About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 8 -

More Related